These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 23665843)
1. Microfluidic chemotaxis platform for differentiating the roles of soluble and bound amyloid-β on microglial accumulation. Cho H; Hashimoto T; Wong E; Hori Y; Wood LB; Zhao L; Haigis KM; Hyman BT; Irimia D Sci Rep; 2013; 3():1823. PubMed ID: 23665843 [TBL] [Abstract][Full Text] [Related]
2. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models. Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S Elife; 2020 Jun; 9():. PubMed ID: 32510331 [TBL] [Abstract][Full Text] [Related]
3. TGF-beta1 blockade of microglial chemotaxis toward Abeta aggregates involves SMAD signaling and down-regulation of CCL5. Huang WC; Yen FC; Shie FS; Pan CM; Shiao YJ; Yang CN; Huang FL; Sung YJ; Tsay HJ J Neuroinflammation; 2010 Apr; 7():28. PubMed ID: 20429874 [TBL] [Abstract][Full Text] [Related]
4. Resting microglia react to Aβ42 fibrils but do not detect oligomers or oligomer-induced neuronal damage. Ferrera D; Mazzaro N; Canale C; Gasparini L Neurobiol Aging; 2014 Nov; 35(11):2444-2457. PubMed ID: 24973120 [TBL] [Abstract][Full Text] [Related]
5. CD36 mediates the innate host response to beta-amyloid. El Khoury JB; Moore KJ; Means TK; Leung J; Terada K; Toft M; Freeman MW; Luster AD J Exp Med; 2003 Jun; 197(12):1657-66. PubMed ID: 12796468 [TBL] [Abstract][Full Text] [Related]
6. The VCAM1-ApoE pathway directs microglial chemotaxis and alleviates Alzheimer's disease pathology. Lau SF; Wu W; Wong HY; Ouyang L; Qiao Y; Xu J; Lau JH; Wong C; Jiang Y; Holtzman DM; Fu AKY; Ip NY Nat Aging; 2023 Oct; 3(10):1219-1236. PubMed ID: 37735240 [TBL] [Abstract][Full Text] [Related]
7. The chemerin receptor CMKLR1 is a functional receptor for amyloid-β peptide. Peng L; Yu Y; Liu J; Li S; He H; Cheng N; Ye RD J Alzheimers Dis; 2015; 43(1):227-42. PubMed ID: 25079809 [TBL] [Abstract][Full Text] [Related]
8. Microglial alterations in human Alzheimer's disease following Aβ42 immunization. Zotova E; Holmes C; Johnston D; Neal JW; Nicoll JA; Boche D Neuropathol Appl Neurobiol; 2011 Aug; 37(5):513-24. PubMed ID: 21166690 [TBL] [Abstract][Full Text] [Related]
9. Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide. Rogers J; Strohmeyer R; Kovelowski CJ; Li R Glia; 2002 Nov; 40(2):260-269. PubMed ID: 12379913 [TBL] [Abstract][Full Text] [Related]
11. Prostaglandin signaling suppresses beneficial microglial function in Alzheimer's disease models. Johansson JU; Woodling NS; Wang Q; Panchal M; Liang X; Trueba-Saiz A; Brown HD; Mhatre SD; Loui T; Andreasson KI J Clin Invest; 2015 Jan; 125(1):350-64. PubMed ID: 25485684 [TBL] [Abstract][Full Text] [Related]
12. Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse Model. Meilandt WJ; Ngu H; Gogineni A; Lalehzadeh G; Lee SH; Srinivasan K; Imperio J; Wu T; Weber M; Kruse AJ; Stark KL; Chan P; Kwong M; Modrusan Z; Friedman BA; Elstrott J; Foreman O; Easton A; Sheng M; Hansen DV J Neurosci; 2020 Feb; 40(9):1956-1974. PubMed ID: 31980586 [No Abstract] [Full Text] [Related]
13. Microglial motility in Alzheimer's disease and after Aβ42 immunotherapy: a human post-mortem study. Franco-Bocanegra DK; George B; Lau LC; Holmes C; Nicoll JAR; Boche D Acta Neuropathol Commun; 2019 Nov; 7(1):174. PubMed ID: 31703599 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms of mononuclear phagocyte recruitment in Alzheimer's disease. Hickman SE; El Khoury J CNS Neurol Disord Drug Targets; 2010 Apr; 9(2):168-73. PubMed ID: 20205643 [TBL] [Abstract][Full Text] [Related]
15. PKC and tyrosine kinase involvement in amyloid beta (25-35)-induced chemotaxis of microglia. Nakai M; Hojo K; Taniguchi T; Terashima A; Kawamata T; Hashimoto T; Maeda K; Tanaka C Neuroreport; 1998 Oct; 9(15):3467-70. PubMed ID: 9855300 [TBL] [Abstract][Full Text] [Related]
16. Isolated amyloid-β(1-42) protofibrils, but not isolated fibrils, are robust stimulators of microglia. Paranjape GS; Gouwens LK; Osborn DC; Nichols MR ACS Chem Neurosci; 2012 Apr; 3(4):302-11. PubMed ID: 22860196 [TBL] [Abstract][Full Text] [Related]
17. Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model. Baik SH; Kang S; Son SM; Mook-Jung I Glia; 2016 Dec; 64(12):2274-2290. PubMed ID: 27658617 [TBL] [Abstract][Full Text] [Related]
18. A central role for astrocytes in the inflammatory response to beta-amyloid; chemokines, cytokines and reactive oxygen species are produced. Johnstone M; Gearing AJ; Miller KM J Neuroimmunol; 1999 Jan; 93(1-2):182-93. PubMed ID: 10378882 [TBL] [Abstract][Full Text] [Related]
19. Neutralization of granulocyte macrophage colony-stimulating factor decreases amyloid beta 1-42 and suppresses microglial activity in a transgenic mouse model of Alzheimer's disease. Manczak M; Mao P; Nakamura K; Bebbington C; Park B; Reddy PH Hum Mol Genet; 2009 Oct; 18(20):3876-93. PubMed ID: 19617638 [TBL] [Abstract][Full Text] [Related]
20. Role of high mobility group protein-1 (HMG1) in amyloid-beta homeostasis. Takata K; Kitamura Y; Kakimura J; Shibagaki K; Tsuchiya D; Taniguchi T; Smith MA; Perry G; Shimohama S Biochem Biophys Res Commun; 2003 Feb; 301(3):699-703. PubMed ID: 12565837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]